Intravenous immunoglobulins: A valuable asset in the treatment of a case of septic febrile ulceronecrotic Mucha-Habermann disease [1]

Dermatology

Volumn 215, Issue 2, 2007, Pages 164-165

  Pyrpasopoulou, A ^a   Athyros, V G ^a,b   Karagiannis, A ^a   Chrysomallis, F ^b   Zamboulis, C ^a  

^a Aristotle University and Hippokration General Hospital   (Greece)

^b ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

Author keywords

Intravenous immunoglobulin; Methotrexate; Mucha Habermann disease, septic febrile ulceronecrotic

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; IMMUNOGLOBULIN; METHOTREXATE; PREDNISOLONE; STEROID; TUMOR NECROSIS FACTOR ANTIBODY;

ADOLESCENT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; DRUG DOSE INCREASE; DRUG MEGADOSE; FEMALE; HUMAN; LABORATORY TEST; LETTER; MORTALITY; MUCHA HABERMANN DISEASE; PITYRIASIS LICHENOIDES; PRIORITY JOURNAL; SKIN BIOPSY; SKIN DISEASE; SKIN NECROSIS; SKIN ULCER;

ADOLESCENT; DRUG THERAPY, COMBINATION; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOLOGIC FACTORS; IMMUNOSUPPRESSIVE AGENTS; METHOTREXATE; NECROSIS; PITYRIASIS LICHENOIDES; PREDNISOLONE; SEPSIS;

EID: 34547806183     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000104271     Document Type: Letter

References (7)

1. Bowers S, Warshaw EM: Pityriasis lichenoides and its subtypes. J Am Acad Dermatol 2006;55:557-572.
2. Aydingoz IE, Kocaayan N, Mansur AT, Pekcan S, Arman A: A case of ulceronecrotic Mucha-Habermann disease with pulmonary involvement. Dermatology 2006;212:388-390.
3. Helmbold P, Gaisbauer G, Fiedler E, Stucker M, Wolter M, Marsch WC: Self-limited variant of febrile ulceronecrotic Mucha-Habermann disease with polyclonal T-cell receptor rearrangement. J Am Acad Dermatol 2006;54:1113-1115.
4. Tsianakas A, Hoeger PH: Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated tumour necrosis factor-α. Br J Dermatol 2005;152:794-799.
5. Campos M, Silvente C, Lecona M, Suarez R, Lazaro P: Epidermolysis bullosa acquisita: diagnosis by fluorescence overlay antigen mapping and clinical response to high-dose intravenous immunoglobulin. Clin Exp Dermatol 2006;31:71-73.
6. Colsky AS: Intravenous immunoglobulin in autoimmune and inflammatory dermatoses: a review of proposed mechanisms of action and therapeutic applications. Dermatol Clin 2000;18:447-457.
7. Jolles S, Hughes J, Whittaker S: Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998;134:80-86.